Clinical studies are an important milestone for the path breaking medical breakthroughs and discoveries
Foster City, CA (PRWEB) October 16, 2014
OMICS Publishing House, a pioneer in open access publishing takes pleasure in inviting researchers, scientists, academicians, and students to be a part of this revolution and contribute their work in the form of research articles and case studies to related journals.
On the occasion of the ‘Global Open Access Week’ and to commemorate the same, OMICS Group has launched the ‘OMICS Group Open Access Week’ from the 20th of October 2014, to the 26th October, 2014. OMICS Group Journals on Clinical Science Research are now offering a special discount of 25% on the article processing charges for the submitted manuscripts during this week which can be availed by authors and researchers alike.
Speaking on this occasion, Dr. Srinubabu Gedela, MD of the OMICS Publishing Group underlined the importance of clinical research on biomedical discoveries. In a statement released earlier this month, he said that, “Clinical research is fundamental in fixing the nation’s healthcare goals as it transforms basic biomedical research into suitable healthcare solutions.”
It has long been known that the teaching tools of medical science are clinical trials. Clinical trials show us what works best and what doesn’t in medicine and healthcare. Clinical studies are an important milestone for the path breaking medical breakthroughs and discoveries. They are the fundamental rule book and guide for physicians and researchers. No drug or treatment is passed for approval in the market without its essential clinical study or trial. Since research work is synonymous to documented research articles in journals, it becomes even more important that access to this knowledge is not limited and is made available to the whole of scientific community and for the benefit of science. At OMICS we believe that scientific knowledge should be accessible to one and all, and hence we have established ourselves in open access publishing.
OMICS Group International is a committed Open Access publisher which publishes more than 400 front-line peer-reviewed, open access journals and organizes over 300 international conferences annually all over the world with the support of nearly 1000 international societies in the fields of medicine, pharmaceutics, chemistry, omics, engineering and technology, and management sciences. OMICS Group journals enjoy the support of three million readers with a strong network of 30,000 researchers who offer their unprecedented support towards the growth of OMICS Group Science Journals.
The below mentioned OMICS Clinical Journals offer a 25% discount for all the articles submitted for publication on the eve of the ‘Golden Open Access Week’:
Journal of Clinical Research & Bioethics
Ancient Diseases & Preventive Remedies
Journal of Clinical & Experimental Ophthalmology
Chemotherapy: Open Access
Journal of Aging Science
JBR Journal of Clinical Diagnosis and Research
Clinics in Mother and Child Health
Researchers can submit their manuscripts at the following link or to the mailing address mentioned below. Authors are expected to clearly mention the name of the journal in the covering letter to which they would like to submit their work.
For any further inquiries please contact:
Robert J Patrick
Clinical Group Journals
731 Gull Ave, Foster City
CA 94404, USA